Table 2.
Grade 0 | Grade 1 | Grade 2 | Grade 3 | Σ | |
---|---|---|---|---|---|
I | 0 (0%) | 0 (0%) | 1 (20%) | 4 (80%) | 5 (100%) |
ILN | 0 (0%) | 0 (0%) | 3 (75%) | 1 (25%) | 4 (100%) |
IC * | 4 (80%) | 1 (20%) | 0 (0%) | 0 (0%) | 5 (100%) |
ICLN ^ | 0 (0%) | 0 (0%) | 2 (50%) | 2 (50%) | 4 (100%) |
Σ | 4 (22.2%) | 1 (5.6%) | 6 (33.3%) | 7 (38.9%) | 18 (100%) |
Grade 0—no changes; Grade 1—mild–focal myocyte damage or small multifocal degeneration with a slight degree of inflammatory process; Grade 2—moderate–extensive myofibrillar degeneration and/or diffuse inflammatory process; Grade 3—severe–necrosis with a diffuse inflammatory process.